{
  "symbol": "VRTX",
  "company_name": "Vertex Pharmaceutic",
  "ir_website": "https://news.vrtx.com/news-releases/news-release-details/vertex-announce-third-quarter-2024-financial-results-november",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Vertex to Announce Third Quarter 2024 Financial Results on November 4th",
          "url": "https://news.vrtx.com/news-releases/news-release-details/vertex-announce-third-quarter-2024-financial-results-november",
          "content": "[Skip to content](#lfg-main-content)\n\n[Skip to Content](#skip-to-content)\n\n[ ![Vertex Pharmaceuticals Newsroom](/sites/g/files/knoqqb86996/themes/site/nir_pid5335/client/images/white-vector.svg) ](//www.vrtx.com/)\n\n**Contact Us** mediainfo@vrtx.com +1 617 341 6992 +44 20 3204 5275\n\n  * [ ](https://twitter.com/VertexPharma)\n  * [ ](https://www.linkedin.com/company/vertex-pharmaceuticals)\n  * [ ](https://www.youtube.com/channel/UCrNu_QIE9exwVQnWKgr1toQ/featured)\n\n\n\n[ ![Vertex Pharmaceuticals Newsroom](/sites/g/files/knoqqb86996/themes/site/nir_pid5335/client/images/white-vector.svg) ](//www.vrtx.com/)\n\n#  Press Release \n\n[Back](#)\n\n[PDF Version](/node/32926/pdf)\n\nOct 10, 2024 \n\n## Vertex to Announce Third Quarter 2024 Financial Results on November 4th\n\nBOSTON--(BUSINESS WIRE)--Oct. 10, 2024-- [Vertex Pharmaceuticals Incorporated](https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.vrtx.com&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=Vertex+Pharmaceuticals+Incorporated&index=1&md5=ec1fb3941157ed9b652d8a3f2fb8d7dd) (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Third Quarter 2024 Earnings Call.” \n\nThe conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at [www.vrtx.com](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.vrtx.com%2F&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=www.vrtx.com&index=2&md5=3b66087401dfc7a5c247c870cdfe1442) in the \"Investors\" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website. \n\n**About Vertex**\n\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. \n\nVertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit [www.vrtx.com](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.vrtx.com%2F&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=www.vrtx.com&index=3&md5=5bb3e9f4e74347cd3d3914f6d7022559) or follow us on [LinkedIn](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvertex-pharmaceuticals%2F&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=LinkedIn&index=4&md5=d5a91bec53fa6d29dbe73be8862ef592), [Facebook](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FVertexPharmaInc&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=Facebook&index=5&md5=dbd9ea7475204a363e1cb5f7c69e4b7d), [Instagram](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fvertexpharmaceuticals%2F&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=Instagram&index=6&md5=836dc1d35c64c6ecdbffca7e91f3c4d6), [YouTube](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2F%40VertexPharmaceuticalsGlobal&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=YouTube&index=7&md5=7d04008d603cf22aeeda26ffac680c28) and [X](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fx.com%2FVertexPharma&esheet=54134342&newsitemid=20241010368265&lan=en-US&anchor=X&index=8&md5=f7bb22e4ce1d286a6f8fa47d6cd4a238). \n\n(VRTX-WEB) \n\n![](https://cts.businesswire.com/ct/CT?id=bwnews&sty=20241010368265r1&sid=acqr8&distro=nx&lang=en)\n\nView source version on [businesswire.com](http://businesswire.com): <https://www.businesswire.com/news/home/20241010368265/en/>\n\n**Vertex Pharmaceuticals Incorporated Investor Relations: **investorinfo@vrtx.com\n\nSource: Vertex Pharmaceuticals Incorporated\n\nWe and our third-party service providers and partners use cookies and related technologies to collect information when you visit or interact with our websites. These technologies are used for different purposes, including to deliver our online services to you, improve your experience, analyze traffic, provide you with tailored content and as further described in our [Global Privacy Notice](https://vrtx.com/international-privacy) and [Cookie Notice](https://www.vrtx.com/row-cookie-notice-english-non-us-residents). We may transfer your personal information to countries other than the country in which the data was originally collected for the purposes described in this Privacy Notice. You can learn more about our use of cookies and related technologies and also manage your cookie preferences for this specific website by clicking the “Manage Preferences” button. By clicking “Accept” you consent to the use of all cookies and related technologies on this website.\n\nManage Preferences Reject All Accept\n\n![Company Logo](https://cdn.cookielaw.org/logos/static/ot_company_logo.png)\n\n## Cookie Preference Center\n\n### Your Privacy\n\n#### Your Privacy\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Click on the different category headings to find out more about the cookies and related technologies (referred to in this notice as “cookies”) on this website, and to change the default settings. You may choose not to allow some types of cookies. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. You can learn more about our use of cookies in our [Cookie Notice](https://www.vrtx.com/row-cookie-notice-english-non-us-residents).\n\n  * ### Essential Cookies\n\n#### Essential Cookies\n\nAlways Active\n\nEssential Cookies\n\nThese cookies are essential to enable you to move around the website and use its features. Without these cookies, certain actions (such as setting privacy preferences or filling in forms) cannot be provided. These cookies are necessary for the website to function and are therefore not optional.\n\n  * ### Performance & Analytics Cookies\n\n#### Performance & Analytics Cookies\n\nPerformance & Analytics Cookies\n\nWe make use of performance and analytics cookies to analyze how our visitors use our website and to monitor website performance. This allows us to provide a high quality experience by customizing our offering and quickly identifying and fixing any issues that arise. For example, we might use performance cookies to keep track of which pages are most popular, which method of linking between pages is most effective, and to determine why some pages are receiving error messages. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our websites. \n\n  * ### Functionality & Preference Cookies\n\n#### Functionality & Preference Cookies\n\nFunctionality & Preference Cookies\n\nWe make use of cookies to provide you with certain functionality on our websites. For example, we may use cookies to remember choices you make (such as your preferred language or the region you are in), to recognize the platform from which you access the site, to enable embedded videos, and to provide enhanced and more personal features so you do not have to provide the same information more than once. These cookies are not used to track your browsing on other sites. \n\n  * ### Targeting & Advertising Cookies\n\n#### Targeting & Advertising Cookies\n\nTargeting & Advertising Cookies\n\nWe and our advertising partners may use cookies to enhance our marketing and advertising campaigns, as well as to deliver content that we believe will be most relevant to you based on your use of our websites. Targeting and advertising cookies track user behavior and store user attributes, such as demographic and interest data, to provide more personalized content (in some cases, including ad content) to visitors both on our websites and once you leave our website, to segment visitors into remarketing campaigns, and help us improve and analyze our digital marketing efforts. These cookies are not essential for the website to function, but you may notice less relevant ads and content (including marketing content) if they are disabled.\n\n\n\n\nBack Button\n\n### Advertising Cookies\n\nFilter Button\n\nConsent Leg.Interest\n\nSelect All Vendors\n\nSelect All Vendors\n\nSelect All Hosts\n\nSelect All\n\nClear Filters\n\nInformation storage and access\n\nApply\n\nConfirm My Choices Reject All Allow All\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        }
      ]
    }
  ]
}